24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart review

Pouya Azar, Victor W. Li, Mohammadali Nikoo, Jennifer LaBranche, James S. H. Wong, Jessica Machado, Tam To, Alaa Al Hawamdeh, Martha J. Ignaszewski, Andrew A. Herring, Marc Vogel, Laura Kehoe, Amer Raheemullah, Ruchi Fitzgerald, Reinhard M. Krausz, Julio S. G. Montaner, Anil R. Maharaj

Open source

DOI: 10.1186/s13722-026-00657-3
Published: 2026-03-13
Container: Addiction Science & Clinical Practice
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13722-026-00657-3,
  title = {24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart review},
  author = {Pouya Azar and Victor W. Li and Mohammadali Nikoo and Jennifer LaBranche and James S. H. Wong and Jessica Machado and Tam To and Alaa Al Hawamdeh and Martha J. Ignaszewski and Andrew A. Herring and Marc Vogel and Laura Kehoe and Amer Raheemullah and Ruchi Fitzgerald and Reinhard M. Krausz and Julio S. G. Montaner and Anil R. Maharaj},
  year = {2026},
  journal = {Addiction Science \&amp; Clinical Practice},
  doi = {10.1186/s13722-026-00657-3},
  url = {https://doi.org/10.1186/s13722-026-00657-3}
}

RIS

TY  - JOUR
TI  - 24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart review
AU  - Pouya Azar
AU  - Victor W. Li
AU  - Mohammadali Nikoo
AU  - Jennifer LaBranche
AU  - James S. H. Wong
AU  - Jessica Machado
AU  - Tam To
AU  - Alaa Al Hawamdeh
AU  - Martha J. Ignaszewski
AU  - Andrew A. Herring
AU  - Marc Vogel
AU  - Laura Kehoe
AU  - Amer Raheemullah
AU  - Ruchi Fitzgerald
AU  - Reinhard M. Krausz
AU  - Julio S. G. Montaner
AU  - Anil R. Maharaj
PY  - 2026
JO  - Addiction Science &amp; Clinical Practice
DO  - 10.1186/s13722-026-00657-3
UR  - https://doi.org/10.1186/s13722-026-00657-3
ER  -

APA

Azar, P., Li, V. W., Nikoo, M., LaBranche, J., Wong, J. S. H., Machado, J., To, T., Hawamdeh, A. A., Ignaszewski, M. J., Herring, A. A., Vogel, M., Kehoe, L., Raheemullah, A., Fitzgerald, R., Krausz, R. M., Montaner, J. S. G., & Maharaj, A. R. (2026). 24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart review. Addiction Science & Clinical Practice. https://doi.org/10.1186/s13722-026-00657-3

Source records

crossref · retrieved 2026-09-26T04:49:40.078Z